Form 4 for ORGO Organogenesis Holdings Inc.
Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0001062993-22-004794 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-17 | 2022-02-15 | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | A - Grant | $0.00 | +280.2K | 412.1K | +212% | $0 |
| D | 2022-02-17 | 2022-02-16 | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | F - Tax | $7.78 | -4,085 | 408.0K | -1.0% | -$31.8K |
| D | 2022-02-17 | 2022-02-15 | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | A - Grant | $0.00 | +664.5K | 664.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-02-15 | A | A | 280,199 | $0.00 | 412,116 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-02-16 | F | D | 4,085 | $7.78 | 408,031 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-02-15 | A | A | 664,532 | $0.00 | 664,532 | D | $8.03 · — to 2032-02-15 | 664,532 Class A Common Stock | (F2) The option becomes exercisable in equal annual installments over four years beginning February 15, 2022. |